On September 24, 2015, the Federal Circuit issued an opinion in Shire LLC v. Amneal Pharm., LLC. The opinion may be of interest to readers of this blog for its holding that a company supplying the active pharmaceutical ingredient to abbreviated new drug application (“ANDA”) filers (so that they can file…
